In glioblastoma, CK2 was reported to phosphorylate and stabilize PRMT6, which enhances the methylation of RCC1, thereby facilitating RCC1 localization in chromatin and contributing to tumorigenicity and progression of glioblastoma [29]. The gene discussed is PRMT6; the disease is glioblastoma.